Natural Antioxidants From Tomato Extract Reduce Blood Pressure in Patients With Grade-1 Hypertension: A Double-Blind, Placebo-Controlled Pilot Study

Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: A double-blind, placebo-controlled pilot study

American Heart Journal ◽

10.1016/j.ahj.2005.05.008 ◽

2006 ◽

Vol 151 (1) ◽

pp. 100.e6-100.e1 ◽

Cited By ~ 103

Author(s):

Yechiel N. Engelhard ◽

Benny Gazer ◽

Esther Paran

Keyword(s):

Blood Pressure ◽

Pilot Study ◽

Natural Antioxidants ◽

Reduce Blood Pressure ◽

Double Blind ◽

Double Blind Placebo ◽

Tomato Extract

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

Yearbook of Cardiology ◽

10.1016/s0145-4145(10)79836-1 ◽

2010 ◽

Vol 2010 ◽

pp. 102-104

Author(s):

W.J. Elliott

Keyword(s):

Blood Pressure ◽

Receptor Antagonist ◽

Resistant Hypertension ◽

Controlled Trial ◽

Reduce Blood Pressure ◽

Endothelin Receptor ◽

Treatment Resistant ◽

Double Blind ◽

Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients - a randomized double-blind placebo-controlled pilot study

Nutrition Journal ◽

10.1186/1475-2891-12-138 ◽

2013 ◽

Vol 12 (1) ◽

Cited By ~ 89

Author(s):

Khaider K Sharafedtinov ◽

Oksana A Plotnikova ◽

Ravilay I Alexeeva ◽

Tatjana B Sentsova ◽

Epp Songisepp ◽

...

Keyword(s):

Blood Pressure ◽

Body Mass Index ◽

Pilot Study ◽

Body Mass ◽

Hypocaloric Diet ◽

Double Blind ◽

Hypertensive Patients ◽

Double Blind Placebo ◽

Probiotic Cheese

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(09)61500-2 ◽

2009 ◽

Vol 374 (9699) ◽

pp. 1423-1431 ◽

Cited By ~ 200

Author(s):

Michael A Weber ◽

Henry Black ◽

George Bakris ◽

Henry Krum ◽

Stuart Linas ◽

...

Keyword(s):

Blood Pressure ◽

Receptor Antagonist ◽

Resistant Hypertension ◽

Controlled Trial ◽

Reduce Blood Pressure ◽

Endothelin Receptor ◽

Treatment Resistant ◽

Double Blind ◽

Faculty Opinions recommendation of A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1184971.647074 ◽

2009 ◽

Author(s):

Mahboob Rahman

Keyword(s):

Blood Pressure ◽

Receptor Antagonist ◽

Resistant Hypertension ◽

Controlled Trial ◽

Reduce Blood Pressure ◽

Endothelin Receptor ◽

Treatment Resistant ◽

Double Blind ◽

Faculty Opinions recommendation of A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1184971.746081 ◽

2009 ◽

Author(s):

David Pollock

Keyword(s):

Blood Pressure ◽

Receptor Antagonist ◽

Resistant Hypertension ◽

Controlled Trial ◽

Reduce Blood Pressure ◽

Endothelin Receptor ◽

Treatment Resistant ◽

Double Blind ◽

Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study

Cardiovascular Diabetology ◽

10.1186/1475-2840-9-6 ◽

2010 ◽

Vol 9 (1) ◽

pp. 6 ◽

Cited By ~ 88

Author(s):

Anne Gill ◽

Byron J Hoogwerf ◽

Jude Burger ◽

Simon Bruce ◽

Leigh MacConell ◽

...

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Heart Rate ◽

Type 2 Diabetes Mellitus ◽

Pilot Study ◽

Double Blind ◽

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal

Case Medical Research ◽

10.31525/ct1-nct04070157 ◽

2019 ◽

Author(s):

Keyword(s):

Pilot Study ◽

Double Blind ◽

Faculty Opinions recommendation of A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1168312.630474 ◽

2009 ◽

Author(s):

Robert Findling

Keyword(s):

Bipolar Disorder ◽

Pilot Study ◽

Double Blind ◽

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13349966.14726746 ◽

2011 ◽

Author(s):

Shafiqul A Sarker

Keyword(s):

Pilot Study ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽